Related Experiment Videos
[Glucocorticoid monotherapy for Cogan syndrome?]
B Terjung1, C Helmchen, W Samtleben
1Medizinische Klinik II, Universität München.
Deutsche Medizinische Wochenschrift (1946)
|August 27, 1993
Summary
Cogan's syndrome, a rare autoimmune disorder, can affect both vision and hearing. Early diagnosis and treatment with glucocorticoids and immunosuppressants are crucial for managing symptoms and preventing recurrence.
Area of Science:
- Ophthalmology
- Audiology
- Rheumatology
Background:
- Cogan's syndrome is a rare autoimmune condition characterized by ocular and audiovestibular inflammation.
- Early identification and intervention are critical for managing this systemic disease.
Observation:
- A 27-year-old woman presented with sudden-onset vertigo, autonomic dysfunction, bilateral hearing loss, tinnitus, iritis, and papillitis.
- Audiometric and caloric tests confirmed audiovestibular impairment.
Findings:
- High-dose glucocorticoid therapy improved ocular symptoms but not hearing loss.
- Recurrence of symptoms occurred with reduced steroid dosage, necessitating the addition of immunosuppressive agents.
- Combination therapy with glucocorticoids and cyclophosphamide, followed by methotrexate, achieved symptom remission.
Implications:
- This case highlights the importance of recognizing the diverse clinical manifestations of Cogan's syndrome.
- Aggressive immunosuppressive therapy may be required for refractory cases or to minimize steroid-related side effects.
- Long-term management strategies are essential for preventing disease relapse and preserving organ function.